CEDAR.Co.,Ltd. (TYO:2435)
Japan
· Delayed Price · Currency is JPY 210.00
-1.00 (-0.47%)
May 28, 2025, 3:30 PM JST
CEDAR.Co.,Ltd. Revenue
In the fiscal year ending March 31, 2025, CEDAR.Co.,Ltd. had annual revenue of 17.83B JPY with 3.03% growth. CEDAR.Co.,Ltd. had revenue of 4.39B in the quarter ending March 31, 2025, with 1.57% growth.
Revenue
17.83B
Revenue Growth
+3.03%
P/S Ratio
0.13
Revenue / Employee
13.39M
Employees
1,332
Market Cap
2.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.83B | 525.00M | 3.03% |
| Mar 31, 2024 | 17.30B | 862.00M | 5.24% |
| Mar 31, 2023 | 16.44B | 693.00M | 4.40% |
| Mar 31, 2022 | 15.75B | 136.00M | 0.87% |
| Mar 31, 2021 | 15.61B | 481.00M | 3.18% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |